Butyrate vs Ovagen
A side-by-side research comparison of Butyrate and Ovagen across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Butyrate | Ovagen |
|---|---|---|
| Full name | Sodium Butyrate / Tributyrin | Ovagen (Liver & GI Peptide Bioregulator) |
| Category | Gut Health | Gut Health |
| Status | Dietary supplement | Research compound (peptide bioregulator) |
| Mechanism | Inhibits histone deacetylases (HDACs) for anti-inflammatory gene expression. Fuels colonocyte mitochondria via beta-oxidation. Strengthens tight junctions by upregulating claudin-1 and ZO-1. Activates GPR109A to suppress NF-κB. | As a signal peptide, it is proposed to regulate gene expression in hepatic and gastrointestinal tissue, supporting protein synthesis, detoxification pathways, and gut-associated immune function. |
| Molecular weight | 110.09 Da (sodium butyrate) | ~ (short peptide) |
| Half-life | ~30-40 minutes (rapidly metabolized by colonocytes) | Short (peptide) |
| Bioavailability | Tributyrin: ~60-80% delivery to colon; sodium butyrate: variable | Oral (encapsulated) or subcutaneous |
| Typical dose | 300-600 mg tributyrin or 500-2000 mg sodium butyrate | ~1-2 capsules/day or short injectable courses |
| Frequency | 2-3x daily with meals | Once daily |
| Route | Oral (enteric-coated or tributyrin pro-drug) | Oral capsule or subcutaneous |
Butyrate reported benefits
- Colonocyte energy support
- Tight junction integrity
- Reduced GI inflammation
- Healthy microbiome support
- Epigenetic modulation (HDAC inhibition)
- Improved insulin sensitivity
Ovagen reported benefits
- Liver function support
- Gastrointestinal tissue support
- Protein synthesis support (proposed)
- Gut-immune resilience
- Short course-based protocol
Related comparisons
Research and educational reference only. Not medical advice.